New diagnosis of multiple myeloma in a patient with mantle cell lymphoma: Shared genetic factors or simple coincidence?

Sikuyayenga, Mutende J; Reeder, Craig B; Mikhael, Joseph R

Sikuyayenga, Mutende J; Reeder, Craig B; Mikhael, Joseph R.

Afiliação

Sikuyayenga MJ; Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, United States.
Reeder CB; Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, United States.
Mikhael JR; Division of Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, United States.

Leuk Res Rep ; 1(1): 7-8, 2012.

Article em En | MEDLINE | ID: mdl-24371760

Palavras-chave

FDG, fluorodeoxyglucose; G-CSF, granulocyte colony-stimulating factor; IgH, immunoglobin heavy (chain); MCL, mantle cell lymphoma; MM, multiple myeloma; Mantle cell lymphoma; Multiple myeloma; PBSCT, peripheral blood stem cell transplantation; VCD, velcade (bortezomib) cyclophosphamide dexamethasone; VDJ, variable, diverse, joining (region); VRD, velcade revlimid (lenalidomide) dexamethasone; t(11;14)(q13;q32)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Leuk Res Rep Ano de publicação: 2012 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google